Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells

被引：309
|
作者：
Goel, A [1 ]
Boland, CR [1 ]
Chauhan, DP [1 ]
机构：
[1] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA
来源：
CANCER LETTERS | 2001年 / 172卷 / 02期
关键词：
curcumin; chemoprevention; colon cancer; cyclooxygenase-1; cyclooxygenase-2;
D O I：
10.1016/S0304-3835(01)00655-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Curcumin, a major yellow pigment and active component of turmeric, has been shown to possess anti-inflammatory and anticancer activities. Cyclooxygenase (COX)-2 plays an important role in colon carcinogenesis. To investigate the effect of curcumin on COX-2 expression, we treated HT-29 human colon cancer cells with various concentrations of curcumin. Curcumin inhibited the cell growth of HT-29 cells in a concentration- and time-dependent manner. Curcumin markedly inhibited the mRNA and protein expression of COX-2, but not COX-1. These data suggest that a non-toxic concentration of curcumin has a significant effect on the in vitro growth of HT-29 cells, specifically inhibits COX-2 expression, and may have value as a safe chemopreventive agent for colon cancer. (C) 2001 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码：111 / 118
页数：8
相关论文
共 50 条
  • [21] Regulated cyclooxygenase-2 (Cox-2) expression to investigate the role of Cox-2 in gastric cancer
    Griffin, NM
    Cox, CM
    Scully, GM
    Doherty, GA
    Fitzgerald, DJ
    GASTROENTEROLOGY, 2004, 126 (04) : A49 - A49
  • [22] Influence of paeonol on expression of COX-2 and p27 in HT-29 cells
    Jun-Mei Ye
    World Journal of Gastroenterology, 2009, 15 (35) : 4410 - 4414
  • [23] INHIBITION OF CYCLOOXYGENASE-2 (COX-2); AN OPPORTUNITY FOR BLADDER CANCER CONTROL
    Kontos, S.
    Kominea, A.
    Koritsiadis, G.
    Simaioforidis, V
    Koritsiadis, S.
    Sotiropoulou-Bonikou, G.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 371 - 371
  • [24] Inhibition of COX-2 does not correlate with ability to induce apoptosis in HT-29 cells.
    McCartney, SA
    Farthing, MJG
    Warner, TD
    GUT, 1999, 44 : A82 - A82
  • [25] The inhibition of cyclooxygenase-2 (COX-2) expression by coxsackie and adenovirus receptor (CAR) in bladder cancer
    Hsieh, JT
    Yang, LY
    Pong, RC
    Saboorian, H
    Sagalowsky, AI
    JOURNAL OF UROLOGY, 2003, 169 (04): : 186 - 186
  • [26] Expression of cyclooxygenase-2 (COX-2) mRNA in human colorectal adenomas
    Hasegawa, K
    Ichikawa, W
    Fujita, T
    Ohno, R
    Okusa, T
    Yoshinaga, K
    Sugihara, K
    EUROPEAN JOURNAL OF CANCER, 2001, 37 (12) : 1469 - 1474
  • [27] Selenomethionine inhibits growth and suppresses cyclooxygenase-2 (COX-2) protein expression in human colon cancer cell lines
    Baines, A
    Taylor-Parker, M
    Goulet, AC
    Renaud, C
    Gerner, EW
    Nelson, MA
    CANCER BIOLOGY & THERAPY, 2002, 1 (04) : 370 - 374
  • [28] Characterization of cyclooxygenase-2 (COX-2) expression and Her2/neu in human breast, colon, and prostate cancer.
    Koki, AT
    Harmon, J
    Woerner, BM
    Zweifel, B
    Leahy, K
    Khan, NK
    Dannenberg, AJ
    Soslow, R
    Seibert, KS
    Tsai, CS
    Masferrer, JL
    CLINICAL CANCER RESEARCH, 2000, 6 : 4486S - 4486S
  • [29] Cyclooxygenase-2 (Cox-2) protein expression and stomach cancer.
    Setiawan, VW
    Rao, JY
    Kurtz, RC
    Zhang, ZF
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1190S - 1190S
  • [30] Cyclooxygenase-2 (COX-2) inhibition limits abnormal COX-2 expression and progressive injury in the remnant kidney
    Fujihara, CK
    Antunes, GR
    Mattar, AL
    Andreoli, N
    Malheiros, DMAC
    Noronha, IL
    Zatz, R
    KIDNEY INTERNATIONAL, 2003, 64 (06) : 2172 - 2181
12345